Brian Blank

Brian Blank is an accomplished chemist with extensive experience in pharmaceutical research and development, currently serving as Principal Scientist at ORIC Pharmaceuticals Inc. since October 2018, where previous roles included Senior Scientist and Scientist. Prior experience includes a contracted Research Scientist position at ORIC Pharmaceuticals and a Scientist II role at REVOLUTION Medicines, where innovations included the design of small molecule inhibitors of protein tyrosine phosphatases. Notable academic contributions include a postdoctoral fellowship at the University of California, San Francisco, focusing on antimalarial compounds, and a Ph.D. in Chemistry from UCLA, where significant advancements in organocatalytic methods were achieved. Earlier work included synthesizing inhibitors for various enzymes during undergraduate studies at San Francisco State University, culminating in dual Bachelor's degrees in Chemistry and Biochemistry.